These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9599241)

  • 1. Isoxazolidine-3,5-dione and noncyclic 1,3-dicarbonyl compounds as hypoglycemic agents.
    Shinkai H; Onogi S; Tanaka M; Shibata T; Iwao M; Wakitani K; Uchida I
    J Med Chem; 1998 May; 41(11):1927-33. PubMed ID: 9599241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Design, synthesis and insulin-sensitizing activity of some peroxisome proliferator-activated gamma agonists].
    Zhong CB; Zhu XJ; Liu ZR; Gao XP; Wang XC
    Yao Xue Xue Bao; 2005 Feb; 40(2):136-40. PubMed ID: 15875669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The chemical structure and pharmacological properties of a novel isoxazolidinedione insulin sensitizer, JTT-501].
    Shinkai H
    Nihon Rinsho; 2001 Nov; 59(11):2207-10. PubMed ID: 11712409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and insulin-sensitizing activity of a novel kind of benzopyran derivative.
    Tang L; Yu J; Leng Y; Feng Y; Yang Y; Ji R
    Bioorg Med Chem Lett; 2003 Oct; 13(20):3437-40. PubMed ID: 14505644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular design, synthesis, and hypoglycemic activity of a series of thiazolidine-2,4-diones.
    Oguchi M; Wada K; Honma H; Tanaka A; Kaneko T; Sakakibara S; Ohsumi J; Serizawa N; Fujiwara T; Horikoshi H; Fujita T
    J Med Chem; 2000 Aug; 43(16):3052-66. PubMed ID: 10956213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substituted tetrahydropyrrolo[2,1-b]oxazol-5(6H)-ones and tetrahydropyrrolo[2,1-b]thiazol-5(6H)-ones as hypoglycemic agents.
    Aicher TD; Balkan B; Bell PA; Brand LJ; Cheon SH; Deems RO; Fell JB; Fillers WS; Fraser JD; Gao J; Knorr DC; Kahle GG; Leone CL; Nadelson J; Simpson R; Smith HC
    J Med Chem; 1998 Nov; 41(23):4556-66. PubMed ID: 9804695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nitrones. 6. Isoxazolidine compounds. 6. Malonic ester addition of nitrones with large N-substituents].
    Stamm H; Steudle H
    Arch Pharm (Weinheim); 1976 Nov; 309(11):935-7. PubMed ID: 1016009
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of action of hypoglycemic effects of an intestine-specific inhibitor of microsomal triglyceride transfer protein (MTP) in obese rats.
    Sakata S; Katsumi S; Mera Y; Kuroki Y; Nashida R; Kakutani M; Ohta T
    J Pharmacol Sci; 2015 Jan; 127(1):103-8. PubMed ID: 25704025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Euglycaemic and biological activities of novel thiazolidine-2,4-dione derivatives.
    de Nanteuil G; Herve Y; Duhault J; Espinal J; Boulanger M; Ravel D
    Arzneimittelforschung; 1995 Nov; 45(11):1176-81. PubMed ID: 8929235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Design, synthesis and insulin-sensitizing activity of indole derivatives].
    Tang L; Yang YS; Ji RY
    Yao Xue Xue Bao; 2006 Mar; 41(3):225-9. PubMed ID: 16758992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses high fat diet-induced obesity and glucose intolerance in Sprague-Dawley rats.
    Hata T; Mera Y; Tadaki H; Kuroki Y; Kawai T; Ohta T; Kakutani M
    Diabetes Obes Metab; 2011 May; 13(5):446-54. PubMed ID: 21255216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quaternary oxazolylpyridinium salts. Oral hypoglycemic agents.
    Wiegand GE; Bauer VJ; Safir SR; Blickens DA; Riggi SJ
    J Med Chem; 1969 Sep; 12(5):943-4. PubMed ID: 5812229
    [No Abstract]   [Full Text] [Related]  

  • 13. 4-(trans-4-Methylcyclohexyl)-4-oxobutyric acid (JTT-608). A new class of antidiabetic agent.
    Shinkai H; Ozeki H; Motomura T; Ohta T; Furukawa N; Uchida I
    J Med Chem; 1998 Dec; 41(27):5420-8. PubMed ID: 9876112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents.
    Henke BR; Blanchard SG; Brackeen MF; Brown KK; Cobb JE; Collins JL; Harrington WW; Hashim MA; Hull-Ryde EA; Kaldor I; Kliewer SA; Lake DH; Leesnitzer LM; Lehmann JM; Lenhard JM; Orband-Miller LA; Miller JF; Mook RA; Noble SA; Oliver W; Parks DJ; Plunket KD; Szewczyk JR; Willson TM
    J Med Chem; 1998 Dec; 41(25):5020-36. PubMed ID: 9836620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthesis and biological activity of a series of benzopyran derivatives].
    Tang L; Yang YS; Ji RY
    Yao Xue Xue Bao; 2008 Feb; 43(2):162-8. PubMed ID: 18507343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a novel class of 1,3-dioxane-2-carboxylic acid derivatives as subtype-selective peroxisome proliferator-activated receptor alpha (PPARalpha) agonists.
    Aoki T; Asaki T; Hamamoto T; Sugiyama Y; Ohmachi S; Kuwabara K; Murakami K; Todo M
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2128-32. PubMed ID: 18280733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on antifungal agents. Novel cis-5-alkyl (or alkenyl)-3-phenyl-3-(1H-azol-1-ylmethyl)-2-methyl-isoxazolidine derivatives.
    Bennett GA; Swift PA; Mullen GB; Mitchell JT; Allen SD; Georgiev VS
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):210-2. PubMed ID: 2334463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybridization of non-sulfonylurea insulin secretagogue and thiazolidinedione-derived insulin sensitizer.
    Kitajima H; Nakamura M; Tamakawa H; Goto N
    Bioorg Med Chem Lett; 2000 Nov; 10(21):2453-6. PubMed ID: 11078199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JTT-501, a novel oral antidiabetic agent, improves insulin resistance in genetic and non-genetic insulin-resistant models.
    Shibata T; Matsui K; Yonemori F; Wakitani K
    Br J Pharmacol; 1998 Dec; 125(8):1744-50. PubMed ID: 9886766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of JTT-501, a new insulin sensitiser, in restoring impaired GLUT4 translocation in adipocytes of rats fed a high fat diet.
    Terasaki J; Anai M; Funaki M; Shibata T; Inukai K; Ogihara T; Ishihara H; Katagiri H; Onishi Y; Sakoda H; Fukushima Y; Yazaki Y; Kikuchi M; Oka Y; Asano T
    Diabetologia; 1998 Apr; 41(4):400-9. PubMed ID: 9562343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.